survival of a severe combined immunodeficiency patient from transfusion-associated graft-versus-host disease: a case report

Patients with severe combined immunodeficiency are at high risk of transfusion associated graft versus host disease (tagvhd) if they receive a non-radiated blood product that has a high mortality rate. this case study reports on the case of a premature baby who had anemia of prematurity with a normal level of wbc. he received packed red blood cells, but after a while, he developed severe nausea and skin lesions. endoscopy was done and the biopsy from the gastrointestinal lesions as well as the biopsy from the skin lesions showed graft versus host disease when he was 6 months old. however, he has received hematopoietic stem cell transplantation and is well now after about 4 months from his transplant.